Here are four latest drugs or medical devices approved by the Food and Drug Administration this week.
1. The TrueTear Intranasal Tear Neurostimulator uses electrical stimulation to temporarily increase tear production in adult patients with dry eye.
2. The cholesterol drug Praluent may now be administered in a once-monthly dose form.
3. Brineura is the first treatment for a specific form of Batten disease, an extremely rare pediatric neurosystem disorder.
4. Stivarga can now be used as a second-line treatment for hepatocellular carcinoma, the most common type of liver cancer.
More articles on supply chain:
Corporate Whistleblower Center encourages pharma employees to report unsanitary drug plant conditions
7 must-reads for supply chain leaders this week
Dem. Senators pen letter to Dr. Scott Gottlieb on FDA hiring freeze